Vicore Pharma Holding AB (publ)
SSE:VICO.ST
Overview | Financials
Company Name | Vicore Pharma Holding AB (publ) |
Symbol | VICO.ST |
Currency | SEK |
Price | 14.38 |
Market Cap | 1,606,576,740 |
Dividend Yield | 0% |
52-week-range | 12.36 - 26.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ahmed S. Mousa J.D. |
Website | https://www.vicorepharma.com |
An error occurred while fetching data.
About Vicore Pharma Holding AB (publ)
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD